IN2014MN01513A - - Google Patents

Download PDF

Info

Publication number
IN2014MN01513A
IN2014MN01513A IN1513MUN2014A IN2014MN01513A IN 2014MN01513 A IN2014MN01513 A IN 2014MN01513A IN 1513MUN2014 A IN1513MUN2014 A IN 1513MUN2014A IN 2014MN01513 A IN2014MN01513 A IN 2014MN01513A
Authority
IN
India
Prior art keywords
subject
allergic
peptides
timothy grass
methods
Prior art date
Application number
Other languages
English (en)
Inventor
Alessandro Sette
Veronique Schulten
Howard Grey
Bjoern Peters
Jason Greenbaum
Original Assignee
Jolla Inst Allergy Immunolog
Alessandro Sette
Veronique Schulten
Howard Grey
Bjoern Peters
Jason Greenbaum
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jolla Inst Allergy Immunolog, Alessandro Sette, Veronique Schulten, Howard Grey, Bjoern Peters, Jason Greenbaum filed Critical Jolla Inst Allergy Immunolog
Publication of IN2014MN01513A publication Critical patent/IN2014MN01513A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
IN1513MUN2014 2012-02-07 2013-02-07 IN2014MN01513A (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261596156P 2012-02-07 2012-02-07
US201261734886P 2012-12-07 2012-12-07
PCT/US2013/025213 WO2013119863A1 (en) 2012-02-07 2013-02-07 Timothy grass allergens and methods and uses for immune response modulation

Publications (1)

Publication Number Publication Date
IN2014MN01513A true IN2014MN01513A (pl) 2015-09-11

Family

ID=48948025

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1513MUN2014 IN2014MN01513A (pl) 2012-02-07 2013-02-07

Country Status (13)

Country Link
US (1) US10428124B2 (pl)
EP (1) EP2812026A4 (pl)
JP (1) JP2015513527A (pl)
KR (1) KR20140129124A (pl)
CN (1) CN104203277A (pl)
AU (1) AU2013216993C1 (pl)
BR (1) BR112014019504A2 (pl)
CA (1) CA2864084A1 (pl)
EA (1) EA201491481A1 (pl)
HK (1) HK1204929A1 (pl)
IN (1) IN2014MN01513A (pl)
MX (1) MX2014009285A (pl)
WO (1) WO2013119863A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015054217A2 (en) 2013-10-07 2015-04-16 La Jolla Institute For Allergy And Immunology Methods and uses for reducing an allergic response in a subject
WO2015054231A1 (en) 2013-10-07 2015-04-16 La Jolla Institute For Allergy And Immunology Methods and uses for identifying responders to allergy therapy
AU2014352986A1 (en) 2013-11-20 2016-06-16 Alk-Abello A/S Pan pollen immunogens and methods and uses thereof for immune response modulation
WO2015077442A2 (en) 2013-11-20 2015-05-28 La Jolla Institute For Allergy And Immunology Grass pollen immunogens and methods and uses for immune response modulation
EP3086806B1 (en) 2013-12-23 2019-12-11 ALK-Abelló A/S Peptide combinations and uses thereof in treating dust mite allergy
WO2015131053A1 (en) 2014-02-28 2015-09-03 Alk-Abelló A/S Polypeptides derived from phl p and methods and uses thereof for immune response modulation
TWI687434B (zh) 2014-10-07 2020-03-11 日商賽多利克公司 使用來自hsp70之胜肽之用於治療或預防癌之醫藥組成物、免疫誘導劑、及抗原呈現細胞之製造方法
TW202115102A (zh) 2015-03-09 2021-04-16 日商賽多利克公司 來自gpc3之胜肽、使用此胜肽之用於治療或預防癌症之醫藥組成物、免疫誘導劑、及抗原呈現細胞之製造方法
BR112017020404A2 (pt) 2015-04-07 2018-07-10 Cytlimic Inc. medicamento
EP3527216B1 (en) 2016-10-11 2024-02-14 NEC Corporation A medicine comprising a toll-like receptor agonist, lag-3 protein, a hsp70-derived peptide and a gpc3-derived peptide
KR20200002888A (ko) * 2017-04-28 2020-01-08 호유 가부시키가이샤 알레르기 항원 및 그 에피토프

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7214786B2 (en) * 2000-12-14 2007-05-08 Kovalic David K Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
AUPR775401A0 (en) * 2001-09-18 2001-10-11 Monash University Novel Epitopes and Uses Thereof
PT1515988E (pt) 2002-06-25 2012-06-25 Merck Patent Gmbh Sequência de adn e produção recombinante do alergénio do pólen das gramíneas phl p4
US7731970B2 (en) 2002-08-19 2010-06-08 Merck Patent Gmbh Variants of the major allergen Phl p 1 from timothy grass
AU2003280324A1 (en) * 2002-11-26 2004-06-18 Alk-Abello A/S Pharmaceutical allergen product
WO2006076423A2 (en) 2005-01-12 2006-07-20 Monsanto Technology, Llc Genes and uses for plant improvement
US20090070897A1 (en) 2006-01-12 2009-03-12 Goldman Barry S Genes and uses for plant improvement
AU2009208390B2 (en) * 2008-02-01 2014-07-17 Prota Therapeutics Pty Ltd A method of inducing tolerance to an allergen
EP2388268A1 (en) * 2010-05-18 2011-11-23 Stallergenes S.A. Recombinant Der p 2 expressed in Pichia pastoris as a "natural-like" allergen for immunotherapy and diagnostic purposes
EP2627355B1 (en) 2010-10-15 2015-08-26 ALK-Abelló A/S Suppression of a hypersensitivity immune response with unrelated antigen derived from allergen source material
US20120100163A1 (en) 2010-10-15 2012-04-26 Alk-Abello A/S Suppression of a type 1 hypersensitivity immune response with an unrelated antigen
AU2013240271A1 (en) 2012-03-26 2014-10-02 Axcella Health Inc. Nutritive fragments, proteins and methods
US20150126459A1 (en) 2012-04-16 2015-05-07 Alk-Abello A/S Plant profilin polypeptides for use in non-specific allergy immunotherapy

Also Published As

Publication number Publication date
US10428124B2 (en) 2019-10-01
EA201491481A1 (ru) 2014-11-28
WO2013119863A1 (en) 2013-08-15
HK1204929A1 (en) 2015-12-11
CN104203277A (zh) 2014-12-10
AU2013216993A1 (en) 2014-08-21
MX2014009285A (es) 2015-02-04
JP2015513527A (ja) 2015-05-14
AU2013216993B2 (en) 2016-09-15
EP2812026A4 (en) 2016-04-27
CA2864084A1 (en) 2013-08-15
KR20140129124A (ko) 2014-11-06
BR112014019504A2 (pt) 2017-06-27
US20150023992A1 (en) 2015-01-22
EP2812026A1 (en) 2014-12-17
AU2013216993C1 (en) 2017-01-19

Similar Documents

Publication Publication Date Title
IN2014MN01513A (pl)
CA2863861A1 (en) Epitopes from allergen proteins and methods and uses for immune response modulation
HK1216487A1 (zh) 具有穩定的乳液體系的基於氨基酸和蛋白水解物的配方食品
MX2016001356A (es) Proteina anti-garp y sus usos.
MX2021006017A (es) Polipeptidos de folistatina y sus usos.
EA201590451A1 (ru) Способ лечения меланомы с применением вируса простого герпеса и ингибитора иммунной контрольной точки
WO2013106834A3 (en) Immunogenic wt-1 peptides and methods of use thereof
SG194755A1 (en) Pre-fusion rsv f antigens
BR112013020500A8 (pt) anticorpo isolado, recombinante ou purificado
BR112015013127A2 (pt) imunoterapia com agentes de ligação
WO2011113019A3 (en) Ctla4 proteins and their uses
BR112016011025A2 (pt) polipeptídeos anticorpo e seus usos
IN2014CN04498A (pl)
TR201905619T4 (tr) Alerji aşısı olarak peptit taşıyıcı füzyon proteinleri.
WO2014204816A3 (en) Method for assessing protein identity and stability
WO2014144721A3 (en) Treating th2-mediated diseases by inhibition of bromodomain-comprising proteins brd7 and brd9
BR112013018742A2 (pt) cya-transportador de polipeptídeo(s) e use para induzir tanto as terapias e resposta imunitária profilática
EP3087185A4 (en) Antibodies comprising c-terminal light chain polypeptide extensions and conjugates and methods of use thereof
EA201491277A1 (ru) Противораковый слитый белок
WO2016131000A3 (en) Tolerance therapeutic for treating polypeptide induced allergy
BR112014011481A2 (pt) hidrolisado de colágeno e seu uso
WO2014082042A3 (en) Peptides that stimulate subcutaneous adipogenesis
BR112014028130A2 (pt) Sal de cloridrato de um peptídeo, composição farmacêutica, uso de um sal de cloridrato, uso de uma composição farmacêutica, e, método para evitar ou tratar alergia a gatos
WO2013095091A3 (en) Rsv g protein specific antibodies
WO2011123858A3 (en) Ccn3 peptides and analogs thereof for therapeutic use